Literature DB >> 21142149

Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.

Tuane C R G Vieira1, Daniel P Reynaldo, Mariana P B Gomes, Marcius S Almeida, Yraima Cordeiro, Jerson L Silva.   

Abstract

The conversion of cellular prion protein (PrP(C)) into the pathological conformer PrP(Sc) requires contact between both isoforms and probably also requires a cellular factor, such as a nucleic acid or a glycosaminoglycan (GAG). Little is known about the structural features implicit in the GAG-PrP interaction. In the present work, light scattering, fluorescence, circular dichroism, and nuclear magnetic resonance (NMR) spectroscopy were used to describe the chemical and physical properties of the murine recombinant PrP 23-231 interaction with low molecular weight heparin (LMWHep) at pH 7.4 and 5.5. LMWHep interacts with rPrP 23-231, thereby inducing transient aggregation. The interaction between murine rPrP and heparin at pH 5.5 had a stoichiometry of 2:1 (LMWHep:rPrP 23-231), in contrast to a 1:1 binding ratio at pH 7.4. At binding equilibrium, NMR spectra showed that rPrP complexed with LMWHep had the same general fold as that of the free protein, even though the binding can be indicated by significant changes in few residues of the C-terminal domain, especially at pH 5.5. Notably, the soluble LMWHep:rPrP complex prevented RNA-induced aggregation. We also investigated the interaction between LMWHep and the deletion mutants rPrP Δ51-90 and Δ32-121. Heparin did not bind these constructs at pH 7.4 but was able to interact at pH 5.5, indicating that this glycosaminoglycan binds the octapeptide repeat region at pH 7.4 but can also bind other regions of the protein at pH 5.5. The interaction at pH 5.5 was dependent on histidine residues of the murine rPrP 23-231. Depending on the cellular milieu, the PrP may expose different regions that can bind GAG. These results shed light on the role of GAGs in PrP conversion. The transient aggregation of PrP may explain why some GAGs have been reported to induce the conversion into the misfolded, scrapie conformation, whereas others are thought to protect against conversion. The acquired resistance of the complex against RNA-induced aggregation explains some of the unique properties of the PrP interaction with GAGs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142149     DOI: 10.1021/ja106725p

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  29 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

3.  Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.

Authors:  Brandon B Holmes; Sarah L DeVos; Najla Kfoury; Mei Li; Rachel Jacks; Kiran Yanamandra; Mohand O Ouidja; Frances M Brodsky; Jayne Marasa; Devika P Bagchi; Paul T Kotzbauer; Timothy M Miller; Dulce Papy-Garcia; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

4.  Mammalian prion amyloid formation in bacteria.

Authors:  Bruno Macedo; Yraima Cordeiro; Salvador Ventura
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

Review 5.  Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases.

Authors:  Yraima Cordeiro; Bruno Macedo; Jerson L Silva; Mariana P B Gomes
Journal:  Biophys Rev       Date:  2014-01-09

6.  The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.

Authors:  Helen M J Klemm; Jeremy M Welton; Colin L Masters; Genevieve M Klug; Alison Boyd; Andrew F Hill; Steven J Collins; Victoria A Lawson
Journal:  J Biol Chem       Date:  2012-08-28       Impact factor: 5.157

7.  Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids.

Authors:  Juliana A P Chaves; Carolina Sanchez-López; Mariana P B Gomes; Tháyna Sisnande; Bruno Macedo; Vanessa End de Oliveira; Carolina A C Braga; Luciana P Rangel; Jerson L Silva; Liliana Quintanar; Yraima Cordeiro
Journal:  J Biol Inorg Chem       Date:  2014-02-21       Impact factor: 3.358

8.  Nucleic acid induced unfolding of recombinant prion protein globular fragment is pH dependent.

Authors:  Alakesh Bera; Pradip K Nandi
Journal:  Protein Sci       Date:  2014-10-28       Impact factor: 6.725

9.  Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.

Authors:  Taslim A Al-Hilal; Seung Woo Chung; Jeong Uk Choi; Farzana Alam; Jooho Park; Seong Who Kim; Sang Yoon Kim; Fakhrul Ahsan; In-San Kim; Youngro Byun
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

10.  Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.

Authors:  Morikazu Imamura; Naoko Tabeta; Nobuko Kato; Yuichi Matsuura; Yoshifumi Iwamaru; Takashi Yokoyama; Yuichi Murayama
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.